HIV News and Research

RSS

NIH halts large clinical trial of HIV vaccine candidate

"The National Institutes of Health on Thursday halted a study testing an experimental HIV vaccine after an independent review board found the vaccine did not prevent HIV infection and did not reduce the amount of HIV in the blood," Reuters reports (Steenhuysen, 4/25).

29 Apr 2013

DKT Ethiopia using GIS technology to improve family planning, HIV prevention programs

"In just six years, DKT Ethiopia has transformed its system for tracking contraceptive sales from pins and pencils to computers and satellites and, in the process, helped create a family planning and HIV prevention success story in the Horn of Africa," David Olson, a global development communications consultant, writes in the Huffington Post's "Global Motherhood" blog.

29 Apr 2013

JHUSON opens registration for first-ever MOOC

Prospective students, lifelong learners, or anyone simply interested in patient safety can get a thorough overview of the topic and a taste of the Johns Hopkins educational experience beginning June 3.

29 Apr 2013

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Pfizer Inc. presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults 18 to 49 years of age.

From Pfizer, Inc. 29 Apr 2013

First Edition: April 26, 2013

Today's headlines include reports that some Democratic senators have concerns about the health law's roll out as well as other news about the measure's implementation.

26 Apr 2013

Obama administration loss in anti-prostitution pledge Supreme Court case would be 'victory for health and human rights'

"No one denies that prostitution can be dangerous, demeaning work. But health experts long ago recognized that sanctions and stigma make it far more harmful," MSNBC.com health policy reporter Geoffrey Cowley writes in an MSNBC.com opinion piece."

26 Apr 2013

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

MDR-TB is tuberculosis, a mycobacterial infection, that has developed resistance to two important and powerful first-line anti-TB drugs, INH and rifampin.

26 Apr 2013

Immudex signs agreement to provide MHC-peptide multimer and Elispot proficiency panel services

Immudex has entered into a strategic agreement with the US Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute, and the European Association for Cancer Immunotherapy (CIMT), under which Immudex will provide MHC-peptide multimer and Elispot proficiency panel services worldwide.

26 Apr 2013

Kaiser Family Foundation, CSIS host panel discussion on IOM's PEPFAR evaluation

On Tuesday, April 30, from 2:00-3:30 p.m., the Kaiser Family Foundation and the Center for Strategic and International Studies (CSIS) Global Health Policy Center will host a panel discussion, titled "The Policy Implications of the Institute of Medicine's Evaluation of PEPFAR," at the CSIS conference center in Washington, D.C.

26 Apr 2013

Blog examines independent evaluation of PMI

While the giant PEPFAR program to fight HIV/AIDS in developing countries gets a lot of attention in U.S. foreign policy discussions, a lesser known initiative to address malaria is achieving sustained, impressive results.

26 Apr 2013

Three steps to eliminating NTDs

In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.

25 Apr 2013

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Devex features a sponsored interview with Dennis Broun, executive director of UNITAID, which uses innovative financing and "its understanding of how to address market shortcomings to improve access to quality-assured treatment and diagnostics for HIV and AIDS, tuberculosis and malaria patients in low-income countries."

25 Apr 2013

Fighting schistosomiasis would help reduce HIV incidence, researchers say

"The transmission of HIV in sub-Saharan Africa could be slashed if efforts are made to combat the spread of the waterborne disease schistosomiasis by providing clean water, sanitation and health education, a study reports," SciDev.Net writes.

25 Apr 2013

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Vertex Pharmaceuticals Incorporated today announced new data from an interim analysis of the exploratory global Phase 3b CONCISE study evaluating the potential to shorten total treatment with telaprevir combination therapy to 12 weeks in certain people with genotype 1 chronic hepatitis C virus infection who have the IL28B CC genotype.

25 Apr 2013

LINCC Initiative to provide charitable contribution to 16 organizations to support individuals with HIV/AIDS

Janssen Therapeutics, Division of Janssen Products, LP, today announced the 16 organizations that will receive a charitable contribution from its Linking In-Need Communities to Care Initiative.

25 Apr 2013

Novel approach using Listeria bacteria shows promise against metastatic pancreatic cancer

Researchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them.

25 Apr 2013

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion

On World Malaria Day, 25 April, WHO recognizes significant accomplishments in preventing and controlling malaria, including in high-burden countries in sub-Saharan Africa, but highlights the threat of antimalarial drug resistance in south-east Asia's Greater Mekong subregion, where an emergency response is now being launched.

25 Apr 2013

Health providers are joining with community organizers, insurers to get the word out on health law benefits

The New York Times examines how the law's backers are working to explain it to the public. Meanwhile, other outlets report on accountable care organizations and concerns -- from business leaders and HIV advocates -- about changes coming from the overhaul.

25 Apr 2013

Supreme Court justices hear arguments in case challenging anti-prostitution pledge

"Supreme Court justices appeared divided on Monday as they considered a challenge to a law requiring non-profit organizations to adopt an anti-prostitution policy in order to obtain federal funding for HIV/AIDS programs abroad," Reuters reports (Hurley, 4/22).

24 Apr 2013

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Results from "Aviator," AbbVie's phase IIb clinical trial of its investigational direct-acting antivirals for the treatment of hepatitis C virus infection, continue to demonstrate high sustained viral response rates against genotype 1 HCV, across patient types.

24 Apr 2013

HIV News and Research

NIH halts large clinical trial of HIV vaccine candidate

DKT Ethiopia using GIS technology to improve family planning, HIV prevention programs

JHUSON opens registration for first-ever MOOC

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

First Edition: April 26, 2013

Obama administration loss in anti-prostitution pledge Supreme Court case would be 'victory for health and human rights'

Multidrug-resistant tuberculosis (MDR-TB): an interview with Dr. Jennifer Cohn, Médecins Sans Frontières

Immudex signs agreement to provide MHC-peptide multimer and Elispot proficiency panel services

Kaiser Family Foundation, CSIS host panel discussion on IOM's PEPFAR evaluation

Blog examines independent evaluation of PMI

Three steps to eliminating NTDs

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Fighting schistosomiasis would help reduce HIV incidence, researchers say

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

LINCC Initiative to provide charitable contribution to 16 organizations to support individuals with HIV/AIDS

Novel approach using Listeria bacteria shows promise against metastatic pancreatic cancer

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion

Health providers are joining with community organizers, insurers to get the word out on health law benefits

Supreme Court justices hear arguments in case challenging anti-prostitution pledge

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News